Oana Pelea, András Tálas, Javier Fernández Carrera, Nicolas Mathis, Lilly van de Venn, Charles D. Yeh, Péter I. Kulcsár, Kim Fabiano Marquart, Yanik Weber, Saskia E. Gerecke, Isabelle F. Harvey-Seutcheu, Dominic Mailänder, Moritz M. Pfleiderer, Christelle Chanez, Jacob E. Corn, Gerald Schwank, Martin Jínek
Site-specific insertion of gene-sized DNA fragments remains an unmet need in the field of genome editing. IS110-family serine recombinases have recently been shown to mediate programmable DNA recombination in bacteria by using a bispecific RNA guide (bridge RNA) that simultaneously recognizes target and donor sites. In this work, we have shown that the bridge recombinase ISCro4 is highly active in human cells and provided structural insights into its enhanced activity. Using plasmid- or all-RNA-based delivery, ISCro4 supports programmable multikilobase excisions and inversions and facilitates donor DNA insertion at genomic sites with efficiencies that exceed 6%. Last, we assessed ISCro4 specificity and off-target activity. These results establish a framework for the development of bridge recombinases as next-generation tools for editing modalities that are beyond the capabilities of current technologies.